CORESTEMCHEMON Statistics

Total Valuation

CORESTEMCHEMON has a market cap or net worth of KRW 268.77 billion. The enterprise value is 300.55 billion.

Market Cap	268.77B
Enterprise Value	300.55B

Important Dates

The last earnings date was Wednesday, November 13, 2024.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

CORESTEMCHEMON has 23.56 million shares outstanding. The number of shares has increased by 15.85% in one year.

Current Share Class	n/a
Shares Outstanding	23.56M
Shares Change (YoY)	+15.85%
Shares Change (QoQ)	+6.93%
Owned by Insiders (%)	16.77%
Owned by Institutions (%)	0.08%
Float	19.60M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	8.20
PB Ratio	13.86
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-8.67
EV / Sales	9.88
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.65

Financial Position

The company has a current ratio of 0.31, with a Debt / Equity ratio of 1.95.

Current Ratio	0.31
Quick Ratio	0.18
Debt / Equity	1.95
Debt / EBITDA	n/a
Debt / FCF	-1.09
Interest Coverage	-5.67

Financial Efficiency

Return on equity (ROE) is -135.91% and return on invested capital (ROIC) is -24.65%.

Return on Equity (ROE)	-135.91%
Return on Assets (ROA)	-15.26%
Return on Capital (ROIC)	-24.65%
Revenue Per Employee	85.72M
Profits Per Employee	-97.59M
Employee Count	355
Asset Turnover	0.33
Inventory Turnover	49.39

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +112.80% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+112.80%
50-Day Moving Average	13,078.60
200-Day Moving Average	11,338.55
Relative Strength Index (RSI)	38.19
Average Volume (20 Days)	203,962

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CORESTEMCHEMON had revenue of KRW 30.43 billion and -34.65 billion in losses. Loss per share was -1,724.47.

Revenue	30.43B
Gross Profit	501.97M
Operating Income	-22.70B
Pretax Income	-34.58B
Net Income	-34.65B
EBITDA	-17.66B
EBIT	-22.70B
Loss Per Share	-1,724.47

Full Income Statement

Balance Sheet

The company has 6.00 billion in cash and 37.78 billion in debt, giving a net cash position of -31.78 billion or -1,349.10 per share.

Cash & Cash Equivalents	6.00B
Total Debt	37.78B
Net Cash	-31.78B
Net Cash Per Share	-1,349.10
Equity (Book Value)	19.39B
Book Value Per Share	823.22
Working Capital	-37.96B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -17.36 billion and capital expenditures -17.37 billion, giving a free cash flow of -34.74 billion.

Operating Cash Flow	-17.36B
Capital Expenditures	-17.37B
Free Cash Flow	-34.74B
FCF Per Share	-1,474.60

Full Cash Flow Statement

Margins

Gross margin is 1.65%, with operating and profit margins of -74.59% and -113.85%.

Gross Margin	1.65%
Operating Margin	-74.59%
Pretax Margin	-113.64%
Profit Margin	-113.85%
EBITDA Margin	-58.04%
EBIT Margin	-74.59%
FCF Margin	-114.14%

Dividends & Yields

CORESTEMCHEMON does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.85%
Shareholder Yield	-15.85%
Earnings Yield	-15.11%
FCF Yield	-12.92%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CORESTEMCHEMON has an Altman Z-Score of -0.89. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.89
Piotroski F-Score	n/a